RNA Manufacturing Videos

  1. Meet Dr. Zoltán Kis And The Wellcome Leap RNA R3 Program 5/22/2023

    In this segment from the Surge Manufacturing for Biopharma Resilience live event, University of Sheffield’s Dr. Zoltán Kis shares the work he’s doing on the Wellcome Leap RNA R3 program.

  2. DNA Vaccine Development In A Global Pandemic: A Personal Account 4/14/2022

    Dr. Gerrit Borchard, University of Geneva, presents a personal account of DNA vaccine development in a global pandemic.

  3. Leading The Genomic Medicine Revolution 4/13/2022

    We work with the world’s leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine.

  4. The Future Of mRNA Manufacturing

    Watch to explore a box solution that provides flexible and scalable options for your mRNA workflows and is designed to support the evolving landscape of mRNA production.

  5. A Double-Edged Sword? Defining "Efficiency" In mRNA Process Development 8/22/2024

    In this clip from a recent Advancing RNA LIVE event, panelists address a question about where the best opportunities exist upstream and/or downstream to increase mRNA manufacturing efficiencies.

  6. Strategies For Scaling Up mRNA Manufacturing To Address Vaccine Demand 4/17/2024

    Learn how flexible approaches can help address the considerations and hurdles in mRNA manufacturing.

  7. New Approaches For Targeted Drug Delivery With Nanomedicines 4/13/2022

    Nanomedicine is a branch of medicine that seeks to apply nanotechnology for disease prevention and/or treatment, imaging, diagnosis, monitoring, and the repair and regeneration of biological systems.

  8. The Market For mRNA Vaccines & Therapeutics 3/14/2022

    As Pfizer and Moderna publicly announce work on an mRNA-based universal flu vaccine, what else is on the horizon for mRNA? Tune in to this segment from the Bioprocess Online Live event mRNA Manufacturing: Bright Future, Big Challenges for a discussion with Roberta Duncan, VP of the mRNA program at Seqirus; Duke Human Vaccine Institute Associate Director of Upstream and Downstream Process Development Jason Dickens, Ph.D.; and Jin Zhou, Executive Director of Process Development for mRNA and Protein Biologics at Ultragenyx. In this clip, they share market forecasts for mRNA vaccines and therapeutics and their companies’ go-forward plans to meet those demands.

  9. A&M STABTEST Shares QC Analysis Of Oligo Therapeutics 9/20/2022

    Explore best practices for developing a QC method for identification and impurity analysis of oligonucleotides, as well as tips on mitigating risk by using compliant instrumentation and software.

  10. An mRNA Wish-List: What Regulatory Developments Would Make Life "Easier?" 5/10/2024

    Three regulatory experts share the topics on which they hope to see further agency clarification in the near-term to help mRNA products make meaningful progress toward/through the clinic.